Correction: Esmaeilzadeh et al. RETRACTED: Identify Biomarkers and Design Effective Multi-Target Drugs in Ovarian Cancer: Hit Network-Target Sets Model Optimizing. Biology 2022, 11, 1851
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsBioinformatics and Genomic Networks · Computational Drug Discovery Methods · Protein Degradation and Inhibitors
A correction has been made to the authorship list of this article [1] and the linked retraction notice [2]. Following the publication of the above-mentioned retraction, the Editorial Office was made aware that certain individuals previously listed as authors were unaware of the submission and did not contribute to the article. As a result, the authorship list of the article [1] and the retraction notice [2] have been updated accordingly. This correction was approved by the Editors-in-Chief. This correction does not affect the content of the retraction notice.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Esmaeilzadeh A.A. Kashian M. Salman H.M. Alsaffar M.F. Jaber M.M. Soltani S. Ilhan A. Bahrami A. RETRACTED: Identify Biomarkers and Design Effective Multi-Target Drugs in Ovarian Cancer: Hit Network-Target Sets Model Optimizing Biology 202211185110.3390/biology 1112185136552360 PMC 9776135 · doi ↗ · pubmed ↗
- 2Biology Editorial Office RETRACTED: Esmaeilzadeh et al. Identify Biomarkers and Design Effective Multi-Target Drugs in Ovarian Cancer: Hit Network-Target Sets Model Optimizing. Biology 2022, 11, 1851 Biology 2024138610.3390/biology 1302008638392351 PMC 10886238 · doi ↗ · pubmed ↗